We read with great interest the article by Mineo and colleagues 1 exploring the role of Fc␥IIB, an inhibitory receptor of Fc␥IIs, on C-reactive protein (CRP)-mediated endothelial dysfunction. Mineo et al examined the mechanisms of CRP actions on endothelium by testing the hypothesis that CRP attenuates endothelial NO synthase (eNOS) activation in vitro. The investigators found that CRPinduced declines in NO production promote monocyte adhesion to endothelium. They further investigated the role of Fc␥ receptors, which display high affinity for CRP and modulate CRP actions. They found that, in Fc␥RIIB ϩ/ϩ mice, CRP blunts acetylcholine-induced increases in carotid artery vascular conductance, and that, in contrast, CRP enhances acetylcholine responses in Fc␥RIIB Ϫ/Ϫ mice. They concluded that Fc␥RIIB mediates CRP inhibition of eNOS.
